HIROTSUバイオサイエンス | 線虫がん検査に関する世界最先端の線虫行動解析技術

NEWS

Cancer test that uses nematodes N-NOSE® （エヌノーズ）

N-NOSE is a cancer screening test takes advantage of the keen olfactory sensors of nematodes. The test has been available to the public in Japan in January 2020.

N-NOSE service site
Learn More

What is N-NOSE?

Merit of taking a cancer screening test

Why nematodes?

The world's first biological ”diagnostic” technology.

At Hirotsu Bio Science, we contribute to the development of revolutionary disease diagnostic technologies to lessen your concerns over health.

Message from CEO
Learn More

Company Profile

Company History

SDGs

List of Officers

News

【Press release】Evaluation of “N-NOSE” on cancer treatment and recurrence

2017.06.14

More

Global CFO Appointed for Overseas Expansion

We as HIROTSU Bio Science Inc. (Head Office: Chiyoda-ku, Tokyo; Representative: Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”) are pleas . . .

[Publication] Romanian research team evaluates “N-NOSE” in the journal “Cancers”

On March 18, 2024, an reveiw articles on cancer screening by a third-party research team (Romania) was published in "Cancers", an oncology journ . . .

Preliminary Cancer Detection Rates After Use of N-NOSE Dogs Released

HIROTSU Bioscience Inc. (Head Office: Chiyoda-ku, Tokyo, Representative: Takaaki Hirotsu, hereinafter referred to as “HIROTSU) has verified the . . .